Table 1 Evolution of consumption in DID of the different families of antiasthmatic drugs

Short-acting inhaled Beta-2-mimetic

1.95

48.87

3.46

51.18

4

27.64

Long-acting inhaled Beta-2-mimetic

0.03

0.76

0.07

1.03

0.04

0.48

Systemic Beta-2-mimetic

0.27

6.9

0.33

0.33

0.35

2.42

Inhaled Glucocorticosteroids alone

0.71

18.15

1.11

16.42

1.13

7.81

Association Beta-2-mimetic /Glucocorticosteroids

-----

------

1.32

19.53

8.53

58.95

Injectable Xanthines

0.95

24.30

0.47

6.95

0.39

2.70

Σ = 3.91

100%

Σ = 6.76

100%

Σ = 14.47

100%